Impact of antiviral therapy on risk prediction model for hepatocellular carcinoma development in patients with chronic hepatitis B.

Hye Yeon Chon Jae Seung Lee Hye-Won Lee Ho Soo Chun Beom Kyung Kim Jun Yong Park Do Young Kim Sang Hoon Ahn Seung-Up Kim

Published in: Hepatology research : the official journal of the Japan Society of Hepatology (2021)

The CU-HCC score significantly decreased at 1 year of AVT and was maintained thereafter. The CU-HCC score after 1 year of AVT independently predicted the risk of HCC development in patients with chronic hepatitis B.

Keyphrases

hepatitis b virus
liver fibrosis
metal organic framework
aqueous solution
bone marrow